Skip to main content
Equibles

Alan Cohen

Arcturus Therapeutics Holdings Inc. (ARCT)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Alan Cohen

Earlier roles on record: Board Member at Trinity Place Holdings Inc. (TPHS) until April 26, 2024 and Board Member at Evolv Technologies Holdings, Inc. (EVLV) until November 2, 2023. Trinity Place Holdings Inc. reported in an 8-K filed May 2, 2024 that Alan Cohen resigned as board of directors, effective April 26, 2024. Evolv Technologies Holdings, Inc. reported in an 8-K filed November 6, 2023 that Alan Cohen resigned as Class II director of the Board, effective November 2, 2023. Evolv Technologies Holdings, Inc. reported in an 8-K filed November 6, 2023 that Alan Cohen resigned as Chairman of the Board, effective November 2, 2023. Alan Cohen has spoken on 1 investor event across 1 company, most recently for Arcturus Therapeutics Holdings Inc. on September 23, 2026.

“on April 26, 2024, Alan Cohen tendered his resignation from the board of directors of the Company, effective immediately.”
Trinity Place Holdings Inc. Form 8-K, filed May 2, 2024 · Read the filing
“On October 31, 2023, Alan Cohen notified the Board of his intention to step down as Chairman of the Board and as a Class II director of the Board, including as a member of the Board's Nominating and Corporate Governance Committee and Technology Committee, effective November 2, 2023.”
Evolv Technologies Holdings, Inc. Form 8-K, filed November 6, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Arcturus Therapeutics Holdings Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.